Author: Marcus Loney-Evans
-
Thanks for helping shape our response to NICE’s draft decision on vorasidenib
Despite the disappointing draft guidance published by NICE, there’s still hope that vorasidenib will be available through the NHS in England.
-
Campaigning together: pushing for change as Parliament returns
In this post we provide an update on recent Campaigns activity including on the Rare Cancers Bill and the NIHR-funded National Brain Tumour Research Consortium.
-
A Bill of Hope: Rare Cancers Bill Passes Committee Stage
“The Rare Cancers Bill, led by Scott Arthur MP, has passed Committee Stage – bringing hope to those affected by rare and less survivable cancers, including brain tumours.”
-
Six ways to remove the barriers to research participation
If we’re going to improve survival rates and quality of life for people with a brain tumour, research must be shaped by those who are eligible to take part.